Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amyris Inc AMRSQ

Chemicals Specialty Chemicals
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F... see more

Recent & Breaking News (GREY:AMRSQ)

BIOSSANCE™ to Launch in Sephora Stores

GlobeNewswire October 31, 2016

Amyris Enters Collaboration with Top 10 Pharmaceutical Company for Biosynthetic Drug Discovery

GlobeNewswire October 28, 2016

Amyris Executes Definitive Collaboration Agreements with Leading Global Nutraceuticals Partner

GlobeNewswire October 26, 2016

Amyris to Announce Third Quarter Financial Results on Wednesday, November 2, 2016

GlobeNewswire October 25, 2016

Specialty Chemicals Stocks Under Scanner -- LyondellBasell Industries, Amyris, International Flavors & Fragrances, and Kronos Worldwide

PR Newswire October 18, 2016

Amyris Agrees to Collaboration Terms with Leading Global Food Ingredients and Nutraceuticals Partner

GlobeNewswire October 13, 2016

Amyris and Autodesk Offer Powerful Open Source Tools for Genetic Design to Enable Rapid DNA Engineering

GlobeNewswire October 4, 2016

Amyris Expands in Global Nutraceuticals Market with New Collaboration and Partner Funding of $30 Million

GlobeNewswire September 30, 2016

Amyris to Present at Singular Research 11th Annual "Best of The Uncovereds" Conference September 22, 2016

GlobeNewswire September 16, 2016

Amyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products

GlobeNewswire September 15, 2016

Amyris in Partnership with Boticário Group Named Gold Winner by Cosmetics Design for Breakthrough Ingredient ─ Neossance® Hemisqualane

GlobeNewswire September 9, 2016

Amyris to Present at Rodman & Renshaw 18th Annual Global Investment Conference on September 12, 2016

GlobeNewswire September 7, 2016

Specialty Chemicals Stocks Technical Reports -- LyondellBasell Industries, Olin, Axalta Coating Systems, and Amyris

PR Newswire August 26, 2016

Biossance™ Launches The Detoxifier ─ A Breakthrough, Innovative Modeling Mask

GlobeNewswire August 24, 2016

Biossance™ Launches The Illuminator ─ A Clinically Proven, Weightless Eye Gel

GlobeNewswire August 17, 2016

Amyris Wins Three-Year, Multi-Million-Dollar Contract from U.S. Department of Energy to Further Manufacturing of Cellulose-Derived Farnesene

GlobeNewswire August 8, 2016

Amyris Reports Second Quarter 2016 Results

GlobeNewswire August 4, 2016

Amyris Enters Partnership with Biogen to Develop Alternative Cell Lines Supporting Production of Therapeutics

GlobeNewswire August 3, 2016

American Refining Group Invests in Novvi to Accelerate Amyris Commercialization of Renewable Base Oil and Lubricant Platform

GlobeNewswire July 19, 2016

Amyris to Announce Second Quarter Financial Results on Thursday, August 4, 2016

GlobeNewswire July 18, 2016